Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ACETAMINOPHEN\PSEUDOEPHEDRINE\TRIPROLIDINE Cause Transient ischaemic attack? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Transient ischaemic attack have been filed in association with ACETAMINOPHEN\PSEUDOEPHEDRINE\TRIPROLIDINE. This represents 5.3% of all adverse event reports for ACETAMINOPHEN\PSEUDOEPHEDRINE\TRIPROLIDINE.

5
Reports of Transient ischaemic attack with ACETAMINOPHEN\PSEUDOEPHEDRINE\TRIPROLIDINE
5.3%
of all ACETAMINOPHEN\PSEUDOEPHEDRINE\TRIPROLIDINE reports
5
Deaths
5
Hospitalizations

How Dangerous Is Transient ischaemic attack From ACETAMINOPHEN\PSEUDOEPHEDRINE\TRIPROLIDINE?

Of the 5 reports, 5 (100.0%) resulted in death, 5 (100.0%) required hospitalization, and 5 (100.0%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ACETAMINOPHEN\PSEUDOEPHEDRINE\TRIPROLIDINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ACETAMINOPHEN\PSEUDOEPHEDRINE\TRIPROLIDINE Cause?

Intentional self-injury (51) Intentional overdose (34) Drug abuse (31) Vomiting (24) Nausea (17) Overdose (12) Headache (10) Suicide attempt (10) Hypertension (9) Tachycardia (9)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Related Pages

ACETAMINOPHEN\PSEUDOEPHEDRINE\TRIPROLIDINE Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack ACETAMINOPHEN\PSEUDOEPHEDRINE\TRIPROLIDINE Demographics